NanoViricides is a development stage company creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide® class drug candidates are designed to specifically attack enveloped virus particles and dismantle them. The company’s development candidates include anti-influenza injectable and oral drugs, both of which are expected to be effective against most types of influenza viruses. The company is also developing drugs against HIV, oral and genital herpes, viral diseases of the eye, and dengue viruses. For more information, visit the company’s website at www.nanoviricides.com.
Let us hear your thoughts below:
